Clinical Research Directory

Inclusion Criteria: 1. Age range 18-75 years, open to both male and female participants; 2. Normal hepatic/renal function and cardiac function; 3. Expected survival of at least 12 weeks; 4. Good adherence to follow-up; 5. Presence of at least one measurable target lesion according to RECIST 1.1 criteria; 6. Women of childbearing age (15-49 years) must undergo a pregnancy test within seven days prior to the commencement of the study and test negative; sexually active male and female participants must agree to utilize effective contraception to prevent pregnancy during the study and for three months following the final examination; 7. Patients for whom a clinical physician recommends PET/CT scans for the diagnosis and staging of tumors; 8. Participants must fully understand and voluntarily agree to participate in the study, and must sign an informed consent form. Exclusion Criteria: 1. Severe abnormalities in liver and renal function and blood counts; 2. Patients planning to conceive; 3. Pregnant or lactating women; 4. Individuals unable to lie flat for thirty minutes; 5. Individuals who refuse to participate in this clinical study; 6. Individuals suffering from claustrophobia or other psychiatric disorders; 7. Other situations deemed unsuitable for trial participation by the researchers.